Plasma neurofilament light chain: A potential prognostic biomarker of dementia in adult Down syndrome patients

Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome

(2018) Andre Strydom et al.   Alzheimers Research & Therapy

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

(2018) Piotr Lewczuk et al.   Alzheimers Research & Therapy

PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI)

(2017) Michael S. Rafii et al.   JOURNAL OF ALZHEIMERS DISEASE

Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syndrome

(2017) Harutsugu Tatebe et al.   Molecular Neurodegeneration

Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod

(2017) Fredrik Piehl et al.   Multiple Sclerosis Journal

Serum neurofilament light in familial Alzheimer disease

(2017) Philip S.J. Weston et al.   NEUROLOGY

The Early Presentation of Dementia in People with Down Syndrome: a Systematic Review of Longitudinal Studies

(2017) Bianca Alexandra Lautarescu et al.   NEUROPSYCHOLOGY REVIEW

Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease

(2017) Niklas Mattsson et al.   JAMA Neurology

Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod

(2017) Fredrik Piehl et al.   Multiple Sclerosis Journal

Increased levels of plasma total tau in adult Down syndrome

(2017) Takashi Kasai et al.   PLoS One

The pattern of amyloid accumulation in the brains of adults with Down syndrome

(2016) Tiina Annus et al.   Alzheimers & Dementia

Dementia in Down's syndrome

(2016) Clive Ballard et al.   LANCET NEUROLOGY

Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases

(2016) Mehtap Bacioglu et al.   NEURON

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study

(2016) Magnus Gisslén et al.   EBioMedicine

A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome

(2015) Frances K. Wiseman et al.   NATURE REVIEWS NEUROSCIENCE

Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction

(2015) Mattias Vågberg et al.   PLoS One

Exploring Alzheimer Molecular Pathology in Down's Syndrome Cerebrospinal Fluid

(2014) Erik Portelius et al.   Neurodegenerative Diseases

Age-Related Changes of Adaptive and Neuropsychological Features in Persons with Down Syndrome

(2014) Alessandro Ghezzo et al.   PLoS One

The population prevalence of Down’s syndrome in England and Wales in 2011

(2013) Jianhua Wu et al.   EUROPEAN JOURNAL OF HUMAN GENETICS